CIK 0001736730 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Camp4 Therapeutics Corp
Sign in to watch- Ticker
- CAMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-651-8867
- Business address
- 100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 16,378 shares at $1.65 ($27,024)
- 4 Open-market buy Chief Medical Officer bought 6,551 shares at $1.65 ($10,809)
- 4 Open-market buy Chief Financial Officer bought 6,551 shares at $1.65 ($10,809)
- 4 Open-market buy Chief Executive Officer bought 6,551 shares at $1.65 ($10,809)
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Shareholder vote results
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 2 of 10 · 193 filings